Inaktiver Wert

Andere Sprachen Sonoma Pharmaceuticals Inc Nasdaq

Aktien

US83558L1052

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results	18.06.
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	17.06.
Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores	09.05.
Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States	10.04.
Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections	05.04.
Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals	28.03.
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results	09.02.
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08.02.
Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-The-Counter Skincare Product for Daily Use	23.01.
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union through Sonoma's Extensive Distributor Network	10.01.
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma?s Extensive Distributor Network	09.01.
Sonoma Pharmaceuticals : Material Agreement - Form 8-K	18.12.
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	13.11.
Sonoma Pharmaceuticals, Inc. Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation At the Symposium on Advanced Wound Care Fall Conference	03.11.
Sector Update: Health Care Stocks Ease in Late Afternoon	26.10.23
Sector Update: Health Care	26.10.23
Top MIdday Decliners	26.10.23
Wall Street Set to Open Lower as GDP, Jobless Claims Higher Than Expected	26.10.23
Sonoma Pharmaceuticals : Investor Presentation October 2023 - Form 8-K	11.10.23
National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced	16.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Sonoma Pharmaceuticals Inc Nasdaq

Aktien

US83558L1052

Andere Sprachen

Filter